Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115054
Chunk: 191

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 191
---
 respectively. The increase was attributed to $0.8 million of interest related to the Revolving Facility and $0.1 million of interest related to deferred consideration for GLOPERBA license acquired from Romeg in 2022.

Liquidity and Capital Resources

As of December 31, 2024, we had cash and cash equivalents of approximately $3.3 million.

We have funded our operations primarily through the Yorkville financing pursuant to the A&R Yorkville Purchase Agreement (as defined below), the B. Riley Principal Capital II, LLC (“B. Riley”) financing pursuant to the B. Riley Purchase Agreement (as defined below), the Revolving Facility, the issuance of the Convertible Debentures and financing pursuant to the ATM Sales Agreement. We also have indebtedness pursuant to the Oramed Note and Tranche B Notes as well as deferred consideration related to the GLOPERBA license acquired**

<div align='center'>121</div>

from Romeg in 2022. The following table summarizes the aggregate indebtedness of these issuances as of December 31, 2024 and December 31, 2023 (in thousands):

| Oramed Note (outstanding principal balance: $25.0 million and $100.9 million as of December 31, 2024 and 2023, respectively) |     | December 31, 
 2024         | 12,161 |     | December 31, 
 2023         | 104,089 |
|:-----------------------------------------------------------------------------------------------------------------------------|:----|:-------------|-------:|:----|:-------------|--------:|
| Convertible Debentures (outstanding principal balance: nil and $4.4 million as of December 31, 2024 and 2023, respectively)  |     |              |      — |     |              |   4,340 |
| Tranche B Notes (outstanding principal balance: $38.0 million and nil as of December 31, 2024 and 2023, respectively)        |     |              | 23,560 |     |              |       — |
| Purchased Revenue Liability                                                                                                  |     |              |  6,800 |     |              |       — |
| Revolving Facility                                                                                                           |     |              |      — |     |              |  17,038 |
| Deferred Consideration with Romeg                                                                                            |     |              |  2,895 |     |              |